Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2018 16:05 ET | Source: Atossa Genetics Inc.

Atossa Genetics Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering

SEATTLE, April 23, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (ATOS) (“Atossa” or the “Company”), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for...
April 20, 2018 08:15 ET | Source: Atossa Genetics Inc.

Atossa Genetics Announces 1 for 12 Reverse Stock Split

SEATTLE, April 20, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
April 16, 2018 08:15 ET | Source: Atossa Genetics Inc.

Atossa Genetics Requests Shareholders to Vote

SEATTLE, April 16, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
April 12, 2018 08:00 ET | Source: Atossa Genetics Inc.

Atossa Genetics Enrolls First Cohort of Eight Subjects in Endoxifen Study of Male Subjects

SEATTLE, April 12, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
March 27, 2018 08:30 ET | Source: Atossa Genetics Inc.

Atossa Genetics Appoints Per Hall, MD, Ph.D. as Scientific Advisor

SEATTLE, March 27, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
March 22, 2018 08:00 ET | Source: Atossa Genetics Inc.

Atossa Genetics Launches Mens’ Breast Health Program

SEATTLE, March 22, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
March 08, 2018 16:05 ET | Source: Atossa Genetics Inc.

Atossa Genetics Announces 2017 Financial Results and Provides Company Update

SEATTLE, March 08, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
February 13, 2018 08:00 ET | Source: Atossa Genetics Inc.

Atossa Genetics to Present at Adoptive T-Cell Therapy Symposium - Molecular Medicine Tri-Conference on Thursday February 15, 2018

SEATTLE, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
February 01, 2018 16:01 ET | Source: Atossa Genetics Inc.

Atossa Genetics Presents Additional Findings from its Phase 1 Study of Oral Endoxifen

SEATTLE, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...
January 31, 2018 08:15 ET | Source: Atossa Genetics Inc.

Atossa Genetics to Host Conference Call to Present Additional Findings from its Phase 1 Study of Oral Endoxifen Thursday February 1, 2018 at 4:30 pm EST

SEATTLE, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other...